Biotricity (NASDAQ:BTCY) Trading 6.2% Higher – Here’s Why

Biotricity, Inc. (NASDAQ:BTCY) traded up 6.2% on Wednesday . The company traded as high as $0.30 and last traded at $0.29. 12,255 shares traded hands during trading, a decline of 84% from the average session volume of 76,445 shares. The stock had previously closed at $0.27.

Analyst Ratings Changes

Separately, HC Wainwright reissued a “neutral” rating on shares of Biotricity in a research note on Monday, November 18th.

Biotricity Stock Up 11.3 %

The business’s 50 day moving average is $0.33 and its two-hundred day moving average is $0.54. The firm has a market cap of $7.76 million, a P/E ratio of -0.23 and a beta of 1.13.

Institutional Trading of Biotricity

An institutional investor recently bought a new position in Biotricity stock. AE Wealth Management LLC acquired a new stake in shares of Biotricity, Inc. (NASDAQ:BTCY) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 97,751 shares of the company’s stock, valued at approximately $88,000. AE Wealth Management LLC owned about 0.45% of Biotricity at the end of the most recent reporting period. Hedge funds and other institutional investors own 3.89% of the company’s stock.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.